These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19203020)

  • 1. Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.
    Nickenig G; Simanenkov V; Lembo G; Rodriguez P; Salko T; Ritter S; Zhang J
    Blood Press Suppl; 2008 Dec; 2():31-40. PubMed ID: 19203020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone.
    Blumenstein M; Romaszko J; Calderón A; Andersen K; Ibram G; Liu Z; Zhang J
    Curr Med Res Opin; 2009 Apr; 25(4):903-10. PubMed ID: 19245300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
    Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
    Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
    J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapy.
    Glorioso N; Thomas M; Troffa C; Argiolas G; Patel S; Baek I; Zhang J
    Curr Vasc Pharmacol; 2012 Nov; 10(6):748-55. PubMed ID: 22303910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients who did not respond fully to amlodipine monotherapy¥.
    Pfeiffer D; Rennie N; Papst CC; Zhang J
    Curr Vasc Pharmacol; 2012 Nov; 10(6):773-80. PubMed ID: 22303911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of aliskiren and aliskiren hydrochlorothiazide (HCT) in a multiethnic, real-world setting.
    Maddury SR; Pande A; Haque KM; Echtay A; Go L; Gulzar T; Kadwa M; Hristoskova S
    Adv Ther; 2013 Feb; 30(2):176-89. PubMed ID: 23354585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Wright M; Lukashevich V; Keefe DL
    Cardiovasc Ther; 2010 Dec; 28(6):344-9. PubMed ID: 20406241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.
    Black HR; Kribben A; Aguirre Palacios F; Bijarnia M; Laflamme AK; Baschiera F
    J Clin Hypertens (Greenwich); 2010 Dec; 12(12):917-26. PubMed ID: 21122057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
    Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
    Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA; Oparil S; Patel S; Fang H; Zhang J
    Adv Ther; 2008 Dec; 25(12):1288-302. PubMed ID: 19066757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.
    Littlejohn TW; Trenkwalder P; Hollanders G; Zhao Y; Liao W
    Curr Med Res Opin; 2009 Apr; 25(4):951-9. PubMed ID: 19257800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study.
    Basile J; Babazadeh S; Lillestol M; Botha J; Yurkovic C; Weitzman R
    J Clin Hypertens (Greenwich); 2011 Mar; 13(3):162-9. PubMed ID: 21366847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with aliskiren/amlodipine combination in patients with moderate-to-severe hypertension: a randomised, double-blind, active comparator trial.
    Braun-Dullaeus RC; Shustov SB; Alvarez C; Rogelio GG; Zhang J; Hristoskova S; Häring DA
    Int J Clin Pract; 2012 Sep; 66(9):834-42. PubMed ID: 22897460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
    Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
    J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of aliskiren/hydrochlorothiazide combination therapy and amlodipine monotherapy in patients with stage 2 systolic hypertension and type 2 diabetes mellitus.
    Townsend RR; Forker AD; Bhosekar V; Yadao A; Keefe DL
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):889-97. PubMed ID: 22142348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
    Black HR; Aguirre P F; Wright M; Alessi T; Baschiera F
    J Clin Hypertens (Greenwich); 2012 Aug; 14(8):514-21. PubMed ID: 22863159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.